Tenaya Therapeutics, Inc. (TNYA): Depreciation & Amortization
$8.44M
Year ended 2025-12-31
$7.15M
Trailing 12 months to 2026-06-30
+9.3%
3-year compound annual growth
+27.7%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.44M | -0.4% | 2026-03-11, From 2025-01-01 |
| 2024-12-31 | $8.47M | -2.5% | 2026-03-11, From 2024-01-01 |
| 2023-12-31 | $8.69M | +34.3% | 2025-03-10, From 2023-01-01 |
| 2022-12-31 | $6.47M | +118.4% | 2024-03-18, From 2022-01-01 |
| 2021-12-31 | $2.96M | +19.3% | 2023-03-08, From 2021-01-01 |
| 2020-12-31 | $2.48M | n/a | 2022-03-23, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | 2025-12-31 | $8.44M | -0.4% |
| Inhibrx Biosciences, Inc. (INBX) | 2025-12-31 | $2.48M | +8.7% |
| ImageneBio, Inc. (IMA) | 2025-12-31 | $400.0K | -63.6% |
| Precision Biosciences Inc (DTIL) | 2025-12-31 | $1.47M | -56.9% |
| Artiva Biotherapeutics, Inc. (ARTV) | 2025-12-31 | $2.60M | +6.8% |
| SAB Biotherapeutics, Inc. (SABS) | 2025-12-31 | $2.99M | -36.4% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $7.32M | +1.5% |
| Caribou Biosciences, Inc. (CRBU) | 2025-12-31 | $3.65M | -7.2% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $8.58M | -3.1% |
Compare TNYA, INBX, IMA, DTIL side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗